RHHVF
Price
$313.62
Change
+$6.20 (+2.02%)
Updated
Apr 17 closing price
Capitalization
250.69B
5 days until earnings call
SNPHF
Price
$10.53
Change
-$0.62 (-5.56%)
Updated
Dec 9 closing price
Capitalization
3.26B
Ad is loading...

RHHVF vs SNPHF

Header iconRHHVF vs SNPHF Comparison
Open Charts RHHVF vs SNPHFBanner chart's image
Roche Holding
Price$313.62
Change+$6.20 (+2.02%)
Volume$105
Capitalization250.69B
Santen Pharmaceutical
Price$10.53
Change-$0.62 (-5.56%)
Volume$299
Capitalization3.26B
RHHVF vs SNPHF Comparison Chart
Loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHVF vs. SNPHF commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a Hold and SNPHF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (RHHVF: $313.62 vs. SNPHF: $10.53)
Brand notoriety: RHHVF and SNPHF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 3% vs. SNPHF: 100%
Market capitalization -- RHHVF: $250.69B vs. SNPHF: $3.26B
RHHVF [@Pharmaceuticals: Major] is valued at $250.69B. SNPHF’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 2 FA rating(s) are green whileSNPHF’s FA Score has 0 green FA rating(s).

  • RHHVF’s FA Score: 2 green, 3 red.
  • SNPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SNPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 3 TA indicator(s) are bullish.

  • RHHVF’s TA Score: 3 bullish, 6 bearish.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а +6.12% price change this week, while SNPHF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.49%. For the same industry, the average monthly price growth was -6.12%, and the average quarterly price growth was -11.03%.

Reported Earning Dates

RHHVF is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.49% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($251B) has a higher market cap than SNPHF($3.26B). RHHVF has higher P/E ratio than SNPHF: RHHVF (19.34) vs SNPHF (15.31). RHHVF YTD gains are higher at: 12.008 vs. SNPHF (0.000). RHHVF has higher annual earnings (EBITDA): 19.1B vs. SNPHF (17.2B). SNPHF has more cash in the bank: 62.3B vs. RHHVF (7.51B). RHHVF has less debt than SNPHF: RHHVF (25.4B) vs SNPHF (40.1B). SNPHF has higher revenues than RHHVF: SNPHF (270B) vs RHHVF (60B).
RHHVFSNPHFRHHVF / SNPHF
Capitalization251B3.26B7,690%
EBITDA19.1B17.2B111%
Gain YTD12.0080.000-
P/E Ratio19.3415.31126%
Revenue60B270B22%
Total Cash7.51B62.3B12%
Total Debt25.4B40.1B63%
FUNDAMENTALS RATINGS
RHHVF vs SNPHF: Fundamental Ratings
RHHVF
SNPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5052
P/E GROWTH RATING
1..100
1241
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (15) in the null industry is somewhat better than the same rating for SNPHF (70). This means that RHHVF’s stock grew somewhat faster than SNPHF’s over the last 12 months.

RHHVF's Profit vs Risk Rating (87) in the null industry is in the same range as SNPHF (100). This means that RHHVF’s stock grew similarly to SNPHF’s over the last 12 months.

RHHVF's SMR Rating (100) in the null industry is in the same range as SNPHF (100). This means that RHHVF’s stock grew similarly to SNPHF’s over the last 12 months.

RHHVF's Price Growth Rating (50) in the null industry is in the same range as SNPHF (52). This means that RHHVF’s stock grew similarly to SNPHF’s over the last 12 months.

RHHVF's P/E Growth Rating (12) in the null industry is in the same range as SNPHF (41). This means that RHHVF’s stock grew similarly to SNPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHVF
RSI
ODDS (%)
Bullish Trend 3 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
51%
Declines
ODDS (%)
Bearish Trend 13 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
Bearish Trend 3 days ago
59%
View a ticker or compare two or three
Ad is loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECDIX15.820.14
+0.89%
Eaton Vance Global Equity Income C
LSMIX12.020.06
+0.50%
Loomis Sayles Small/Mid Cap Growth Instl
CBLRX48.340.08
+0.17%
Columbia Balanced R
GTCIX16.750.02
+0.12%
Glenmede Disciplined International EqPtf
MBCLX18.65-0.07
-0.37%
MassMutual Blue Chip Growth Adm

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
+2.02%
RHHBY - RHHVF
65%
Loosely correlated
+0.83%
JNJ - RHHVF
31%
Poorly correlated
+2.31%
NVS - RHHVF
27%
Poorly correlated
+1.17%
AZN - RHHVF
26%
Poorly correlated
+0.81%
RHHBF - RHHVF
25%
Poorly correlated
+6.32%
More

SNPHF and

Correlation & Price change

A.I.dvisor tells us that SNPHF and RHHVF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHF and RHHVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHF
1D Price
Change %
SNPHF100%
N/A
RHHVF - SNPHF
7%
Poorly correlated
+2.02%
PTKFY - SNPHF
6%
Poorly correlated
N/A
PTKFF - SNPHF
2%
Poorly correlated
N/A
RHHBY - SNPHF
2%
Poorly correlated
+0.83%
SNPHY - SNPHF
1%
Poorly correlated
+1.71%
More